Shared Instrumentation Grant Program
Page 2

The types of research instruments that can be purchased under this program are nuclear magnetic resonance systems, electron and confocal microscopes, mass spectrometers, protein and DNA sequencers, biosensors, x-ray diffractometers and cell sorters.

The minimum cost of the instruments will be $100,000 each, and the maximum amount that will be granted per application will be $600,000.

The institutions and organizations that will be eligible to submit an application under the Shared Instrumentation Grant Program are the following:

a) Public/State Controlled Institutions of Higher Education

b) Private Institutions of Higher Education

c) Hispanic-serving Institutions

d) Historically Black Colleges and Universities (HBCUs)

e) Tribally Controlled Colleges and Universities (TCCUs)

f) Alaska Native and Native Hawaiian Serving Institutions

g) Nonprofit Organizations Other Than Institutions of Higher Education

The Department of Health and Human Services, the mother agency that is funding the Shared Instrumentation Grant Program, is the nation's principal agency that is largely responsible for protecting the health of all Americans and ensuring the provision of fundamental health and human services to all people needing such services.

Shared Instrumentation Grant Program
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Cancer Research Network: a Research Resource within Health Care Delivery System
In cooperation with the National Cancer Institute, the National Institute of Health has recently announced a funding opportunity to support the Cancer Research Network(CRN) in its quest in reshaping the its organization to become a more broader resource for cancer researchers.

---

Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---